Genomics, the study of the complete set of an organism’s genetic material, is becoming an important factor in medical decision-making. In a progressing number of disciplines, the patient’s genomic data is used as a starting point for the diagnostic or therapeutic process. Where in the past genomics was a field of research that was exclusively carried out at large, specialized companies, over the years it has become a standard process in smaller laboratories as well.
Micronit started more than ten years ago as a supplier of genomics consumables and is now one of the key suppliers in this dynamic industry. Our flagship product, a flow cell used for next generation DNA sequencing, has sold over 2 million units over the years to biotech companies worldwide. Our customers, varying from ambitious start-ups to one of the key global players in the next gen sequencing market, rely on our track record of years of supplying our optical grade, high-quality flow cells.
Currently, an estimated 25% of all sequencing platforms worldwide is using flow cells manufactured by Micronit. Our products are used for cancer research, hereditary diseases, forensics, and currently they are also used to analyze SARS-CoV-2. By continuously sequencing samples of the virus, new and emerging variants can immediately be recognized and analyzed. Partly due to these developments, the growth potential for sequencing products is unprecedented.